Evidence map›Paper›PMID 40276804›Full record

ArticleBiotechnology and bioengineering2025

A Mathematical Model for Determining Probabilistic Design Space in Mesenchymal Stem Cell Passage Culture.

Keita Hirono, Yusuke Hayashi, Yuuki Ogawa, Masahiro Kino-Oka, Hirokazu Sugiyama

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Keita HironoDepartment of Chemical System Engineering, The University of Tokyo, Tokyo, Japan.
Yusuke HayashiDepartment of Chemical System Engineering, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2365-1220
Yuuki OgawaDepartment of Biotechnology, Graduate School of Engineering, The University of Osaka, Osaka, Japan.
Masahiro Kino-OkaDepartment of Biotechnology, Graduate School of Engineering, The University of Osaka, Osaka, Japan.ORCID http://orcid.org/0000-0002-4912-5811
Hirokazu SugiyamaDepartment of Chemical System Engineering, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3067-030X

Funding

This study was supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP20be0704001. HK is grateful for the financial support of Grant-in-Aid for JSPS Fellows [Grant Number JP23KJ0375].
6 · The paper itself

Abstract

With their many therapeutic functions, mesenchymal stem cells (MSCs) are promising sources for regenerative medicine. However, in the manufacture of MSCs, without a method for exploring the effects of long-term passage on cell proliferation potentials, the design of passage culture processes is challenging. Here, for the process design of the MSC passage culture, we propose a model for predicting the growth rate as a function of the cumulative population doubling level (cPDL) for each passage. Three steps were implemented: (1) passage culture experiments to correlate apparent growth rate with cPDL were conducted, (2) a model for predicting the growth rate as a function of cPDL was developed, and (3) a model to design the passage culture of MSCs from bone marrow (BM-MSCs) and umbilical cord (UC-MSCs) with stochastic simulation was applied. Two design variables (passage number and harvesting time) were investigated to define feasible operation regions as probabilistic design spaces to meet three quality indicators (senescence level, confluency level, and total number of cells) with given probabilities. Consequently, 10 and 62 conditions out of 165 were identified as feasible for BM- and UC-MSCs, respectively, which would contribute to the industrial MSC passage culture process design.

Indexed as

Cell Culture TechniquesMesenchymal Stem CellsModels, BiologicalBone Marrow CellsCell ProliferationCells, CulturedHumansdesign spacemathematical modelingquality by design (QbD)regenerative medicinestem cell manufacturingstochastic simulation

Identifiers

PMID40276804
PMCPMC12235243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.